In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their impact on cardiovascular outcomes. But do these pleiotropic effects matter, or is ta all down to lipid lowering? At the University of Iowa, Jennifer Robinson has been trying to find out.
[audio:https://www.audiomedica.com/podcasting/aha2005/Jennifer_Robinson.mp3]
The Wingspan Stent: Safe Intra-Cranial Angioplasty? 9 Feb, 2007 Central Pressure And New Goals: Should Be Hypertension Therapy Priorities 6 Jul, 2009 Audio Journal of Cardiovascular Medicine: May 2006 – In the company of James Tcheng 21 May, 2006 Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction 26 Mar, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
